Comparison Chart Exelixis, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 13:48:40 2024-05-15 EDT			5-day change	1st Jan Change
21.2 ^USD	+1.02%		-1.46%	-11.32%

05-14	Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target	MT
05-10	Exelixis Files Patent Complaint Against Cipla's Cancer Treatment	DJ

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	EXELIXIS, INC.	Bio Therapeutic Drugs	+1.31%	-1.46%	-11.32%	+9.10%	+10.06%	6.11B